Skip to content
Pompe Disease News logo
  • About Pompe
    What is Pompe disease?
    Types
    Symptoms
    Causes
    Diagnosis
    Treatment options
    • Lumizyme
    • Nexviazyme
    • Pombiliti + Opfolda
  • News
  • Columns
    Powering Through Pompe — Keara Engle
    Archived columns
    • The Pompe Community Diaries – Anthony Wu
    • On the Road to Pompe — Dwayne Wilson
  • Featured topics
    Living with Pompe
    • Pompe service dog
    • Adaptive clothing
    • Living with Pompe disease
    • ERT and enzyme stabilizers
    • The ERT process
    • Your daily routine with LOPD
    • Adaptive equipment
    • Late-onset Pompe disease
    • Dwayne’s story
    • Expert voice: Safe and effective exercise
    • View all
    Pompe pathways
    • ERT home infusions
    • Therapeutic crossroads
    • Tips for caregivers
    • Maximizing doctor’s appointments
    • Building an LOPD care team
    • Financial planning with Pompe
    • Work and Pompe
    • Occupational therapy
    • Pompe and pain
  • FAQs
  • Advocacy partners
  • What can we help you find today?

August 1, 2018 News by Ana Pena, PhD

Immunomodulation Plus Myozyme May Help Infants with Pompe Disease, But Seen to Carry Risks in Study

Adding immunomodulatory medicines to enzyme replacement therapy (ERT) — Myozyme (alglucosidase alfa) — gives temporary but not long-term protection from antibodies that can block ERT’s effectiveness in patients with classic infantile Pompe disease. Better immunomodulatory regimens are needed to induce long-term…

June 14, 2018 News by Alice Melao

Infantile-onset Pompe Disease Cases Highlight Importance of Early Diagnosis, Treatment

Four cases of infantile-onset Pompe disease recently reported in Australia help shed light on some of the unique challenges care providers face in diagnosing and managing this genetic disease. Early recognition of the disease’s signs and prompt initiation of enzyme replacement therapy (ERT) are critical to ensuring the best patient outcome…

May 16, 2018 News by Alice Melao

ERT Fails to Prevent Long-Term Effects of Infantile Pompe Disease to Brain, Study Shows

Treatment with enzyme replacement therapy can help children with classic infantile Pompe disease reach adulthood. However, it fails to prevent the long-term effects of the disease in the brain and consequent   development of intellectual disabilities, a study shows. The study titled “Classic infantile Pompe patients…

Recent Posts

  • COL13A1 gene levels may link to Pompe neuromuscular dysfunction
  • Having a nurse at home over the summer has been a big help
  • GC301 gene therapy improves motor function in IOPD children


Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

Bionews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: [email protected]
Phone: 1-800-936-1363

  • About Us
  • Leadership
  • Our Culture
  • Editorial Policy
  • Advertising Policy
  • Corrections Policy
  • Terms of Service
  • Privacy Policy
  • Careers
  • Contact Us
Disclaimer

This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2025 All rights reserved.